vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Seer, Inc. (SEER). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $4.2M, roughly 14.8× Seer, Inc.). Cytek Biosciences, Inc. runs the higher net margin — -70.9% vs -380.7%, a 309.8% gap on every dollar of revenue. On growth, Cytek Biosciences, Inc. posted the faster year-over-year revenue change (8.1% vs 5.0%). Cytek Biosciences, Inc. produced more free cash flow last quarter ($-1.8M vs $-11.1M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 17.1%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Seer, Inc. is an American biotechnology company headquartered in Redwood City, California. Established in 2017, the company develops technologies for proteomics research.
CTKB vs SEER — Head-to-Head
Income Statement — Q4 2025 vs Q4 2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $4.2M |
| Net Profit | $-44.1M | $-16.0M |
| Gross Margin | 52.9% | 52.0% |
| Operating Margin | -9.0% | -413.8% |
| Net Margin | -70.9% | -380.7% |
| Revenue YoY | 8.1% | 5.0% |
| Net Profit YoY | -557.1% | 26.4% |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $4.2M | ||
| Q3 25 | $52.3M | $4.1M | ||
| Q2 25 | $45.6M | $4.1M | ||
| Q1 25 | $41.5M | $4.2M | ||
| Q4 24 | $57.5M | $4.0M | ||
| Q3 24 | $51.5M | $4.0M | ||
| Q2 24 | $46.6M | $3.1M | ||
| Q1 24 | $44.9M | $3.1M |
| Q4 25 | $-44.1M | $-16.0M | ||
| Q3 25 | $-5.5M | $-18.2M | ||
| Q2 25 | $-5.6M | $-19.4M | ||
| Q1 25 | $-11.4M | $-19.9M | ||
| Q4 24 | $9.6M | $-21.7M | ||
| Q3 24 | $941.0K | $-21.3M | ||
| Q2 24 | $-10.4M | $-22.9M | ||
| Q1 24 | $-6.2M | $-20.7M |
| Q4 25 | 52.9% | 52.0% | ||
| Q3 25 | 52.7% | 51.2% | ||
| Q2 25 | 52.3% | 52.1% | ||
| Q1 25 | 48.6% | 49.0% | ||
| Q4 24 | 58.5% | 50.6% | ||
| Q3 24 | 56.3% | 48.1% | ||
| Q2 24 | 54.6% | 56.3% | ||
| Q1 24 | 51.3% | 44.4% |
| Q4 25 | -9.0% | -413.8% | ||
| Q3 25 | -17.6% | -469.4% | ||
| Q2 25 | -23.3% | -506.8% | ||
| Q1 25 | -36.1% | -493.0% | ||
| Q4 24 | 5.2% | -587.2% | ||
| Q3 24 | -8.2% | -603.3% | ||
| Q2 24 | -18.3% | -882.0% | ||
| Q1 24 | -23.9% | -821.7% |
| Q4 25 | -70.9% | -380.7% | ||
| Q3 25 | -10.5% | -442.5% | ||
| Q2 25 | -12.2% | -479.5% | ||
| Q1 25 | -27.5% | -474.4% | ||
| Q4 24 | 16.8% | -543.6% | ||
| Q3 24 | 1.8% | -529.0% | ||
| Q2 24 | -22.4% | -743.8% | ||
| Q1 24 | -13.8% | -674.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.35 | ||
| Q2 24 | — | $-0.35 | ||
| Q1 24 | — | $-0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $47.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $259.3M |
| Total Assets | $461.5M | $296.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $47.3M | ||
| Q3 25 | $93.3M | $45.0M | ||
| Q2 25 | $75.5M | $37.9M | ||
| Q1 25 | $95.3M | $52.4M | ||
| Q4 24 | $98.7M | $40.8M | ||
| Q3 24 | $162.3M | $37.6M | ||
| Q2 24 | $177.9M | $31.9M | ||
| Q1 24 | $168.8M | $54.4M |
| Q4 25 | $341.7M | $259.3M | ||
| Q3 25 | $378.6M | $271.8M | ||
| Q2 25 | $377.6M | $288.3M | ||
| Q1 25 | $379.6M | $311.0M | ||
| Q4 24 | $395.7M | $327.6M | ||
| Q3 24 | $385.5M | $344.7M | ||
| Q2 24 | $389.1M | $364.7M | ||
| Q1 24 | $392.6M | $383.6M |
| Q4 25 | $461.5M | $296.1M | ||
| Q3 25 | $494.9M | $308.6M | ||
| Q2 25 | $493.3M | $322.5M | ||
| Q1 25 | $482.6M | $347.3M | ||
| Q4 24 | $499.5M | $366.6M | ||
| Q3 24 | $491.2M | $383.4M | ||
| Q2 24 | $483.7M | $406.6M | ||
| Q1 24 | $492.1M | $422.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $-10.8M |
| Free Cash FlowOCF − Capex | $-1.8M | $-11.1M |
| FCF MarginFCF / Revenue | -2.9% | -264.2% |
| Capex IntensityCapex / Revenue | 1.6% | 7.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-46.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $-10.8M | ||
| Q3 25 | $-3.9M | $-7.6M | ||
| Q2 25 | $108.0K | $-14.7M | ||
| Q1 25 | $-125.0K | $-11.4M | ||
| Q4 24 | $2.0M | $-11.5M | ||
| Q3 24 | $13.2M | $-14.1M | ||
| Q2 24 | $6.2M | $-10.1M | ||
| Q1 24 | $4.0M | $-10.5M |
| Q4 25 | $-1.8M | $-11.1M | ||
| Q3 25 | $-4.6M | $-7.8M | ||
| Q2 25 | $-1.5M | $-15.2M | ||
| Q1 25 | $-974.0K | $-12.1M | ||
| Q4 24 | $1.1M | $-12.0M | ||
| Q3 24 | $12.2M | $-16.3M | ||
| Q2 24 | $5.2M | $-11.2M | ||
| Q1 24 | $3.4M | $-11.2M |
| Q4 25 | -2.9% | -264.2% | ||
| Q3 25 | -8.7% | -190.5% | ||
| Q2 25 | -3.2% | -375.9% | ||
| Q1 25 | -2.3% | -287.1% | ||
| Q4 24 | 1.9% | -299.8% | ||
| Q3 24 | 23.7% | -404.7% | ||
| Q2 24 | 11.0% | -366.0% | ||
| Q1 24 | 7.6% | -365.6% |
| Q4 25 | 1.6% | 7.0% | ||
| Q3 25 | 1.3% | 6.9% | ||
| Q2 25 | 3.5% | 14.0% | ||
| Q1 25 | 2.0% | 15.6% | ||
| Q4 24 | 1.6% | 13.4% | ||
| Q3 24 | 2.0% | 54.4% | ||
| Q2 24 | 2.3% | 38.2% | ||
| Q1 24 | 1.3% | 24.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.21× | — | ||
| Q3 24 | 14.05× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
SEER
Segment breakdown not available.
